Evidence map›Paper›PMID 36009133›Full record

ArticleBrain sciences2022

The Relationship between Oxidative Stress and Subjective Sleep Quality in People with Coronary Artery Disease.

Vivian Feng, Shankar Tumati, Ruoding Wang, Kritleen K Bawa, Damien Gallagher, Nathan Herrmann, Susan Marzolini, Paul Oh, Ana Andreazza, Krista L Lanctôt

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Role of sleep disorders in patients with cardiovascular disease: A systematic review.International journal of cardiology. Cardiovascular risk and prevention · 2024
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Vivian FengNeuropsychopharmacology Research Group, Sunnybrook Research Institute, 2075 Bayview Avenue, Room FG21, Toronto, ON M4N 3M5, Canada.ORCID 0000-0002-5849-5590
Shankar TumatiNeuropsychopharmacology Research Group, Sunnybrook Research Institute, 2075 Bayview Avenue, Room FG21, Toronto, ON M4N 3M5, Canada.
Ruoding WangNeuropsychopharmacology Research Group, Sunnybrook Research Institute, 2075 Bayview Avenue, Room FG21, Toronto, ON M4N 3M5, Canada.
Kritleen K BawaNeuropsychopharmacology Research Group, Sunnybrook Research Institute, 2075 Bayview Avenue, Room FG21, Toronto, ON M4N 3M5, Canada.
Damien GallagherNeuropsychopharmacology Research Group, Sunnybrook Research Institute, 2075 Bayview Avenue, Room FG21, Toronto, ON M4N 3M5, Canada.
Nathan HerrmannNeuropsychopharmacology Research Group, Sunnybrook Research Institute, 2075 Bayview Avenue, Room FG21, Toronto, ON M4N 3M5, Canada.
Susan MarzoliniKITE Toronto Rehabilitation Institute, University Health Network, East York, ON M5G 2A2, Canada.ORCID 0000-0002-3186-400X
Paul OhKITE Toronto Rehabilitation Institute, University Health Network, East York, ON M5G 2A2, Canada.
Ana AndreazzaDepartment of Pharmacology and Toxicology, University of Toronto, Toronto, 1 King's College Cir, Toronto, ON M5S 1A8, Canada.ORCID 0000-0002-4323-7273
Krista L LanctôtNeuropsychopharmacology Research Group, Sunnybrook Research Institute, 2075 Bayview Avenue, Room FG21, Toronto, ON M4N 3M5, Canada.ORCID 0000-0001-7024-6637
University of New Brunswick · CASunnybrook Health Science Centre · CAUniversity Health Network · CA

Funding

Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)R01AG046543 · NIA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HERRMANN, NATHAN, LANCTOT, KRISTA L. · 2014 to 2018
$8.1M
Alzheimer's Association PTCG-20-700751Alzheimer's Drug Discovery Foundation 2016354CIHR PJ2-179753, PJT-183584NIA NIH HHS R01AG046543Weston Family Foundation CT190002
6 · The paper itself

Abstract

background(1) Sleep disorders are prevalent in coronary artery disease (CAD) patients and predict cardiac events and prognosis. While increased oxidative stress (OS) has been associated with sleep disorders, less is known about its relationship with sleep quality. Similarly, little is known of how this relationship might change with exercise, which can improve sleep quality. Factors of sleep quality, such as sleep duration and disturbances, are also important as they predict cardiovascular diseases better than a global score alone. This study investigated whether OS was associated with self-rated sleep quality and its factors before and after completing a 24-week exercise intervention. (2) Methods: CAD patients undergoing an exercise program were recruited. OS was measured at baseline by the concentrations of early- (lipid hydroperoxides, LPH) and late-stage (8-isoprostane, 8-ISO) lipid peroxidation products and their ratio. Sleep quality was measured by the self-reported Pittsburgh Sleep Quality Index (PSQI) instrument at baseline and termination. Three sleep factors-perceived sleep quality, sleep efficiency, and daily disturbances-were derived from the PSQI. (3) Results: Among CAD patients (

Indexed as

coronary artery diseaseoxidative stresssleep quality

Identifiers

PMID36009133
PMCPMC9406162
OpenAlexW4291415490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.